Mostrar el registro sencillo del ítem
| dc.contributor.author | Groot, Colin | |
| dc.contributor.author | Calandri, Ismael Luis | |
| dc.contributor.author | Bader, Ilse | |
| dc.contributor.author | Bocancea, Diana I. | |
| dc.contributor.author | de Bruin, Hannah | |
| dc.contributor.author | Carrigan, Maria | |
| dc.contributor.author | Kamps, Suzie | |
| dc.contributor.author | de Koning, Lotte A. | |
| dc.contributor.author | Mastenbroek, Sophie E. | |
| dc.contributor.author | Rikken, Roos M. | |
| dc.contributor.author | van Tol, Bastiaan G. J. | |
| dc.contributor.author | Vermeiren, Marie R. | |
| dc.contributor.author | Wesseling, Alex | |
| dc.contributor.author | Xia, Ye | |
| dc.contributor.author | Teunissen, Charlotte E. | |
| dc.contributor.author | van de Giessen, Elsmarieke | |
| dc.contributor.author | Barkhof, Frederik | |
| dc.contributor.author | Jonkman, Laura E. | |
| dc.contributor.author | van der Lee, Sven J. | |
| dc.contributor.author | de Boer, Casper | |
| dc.date.accessioned | 2026-08-12T14:37:59Z | |
| dc.date.available | 2026-08-12T14:37:59Z | |
| dc.date.issued | 2026-01-07 | |
| dc.identifier.citation | Groot C, Calandri IL, Bader I, Bocancea DI, de Bruin H, Carrigan M, Kamps S, de Koning LA, Mastenbroek SE, Rikken RM, van Tol BGJ, Vermeiren MR, Wesseling AJ, Xia Y, Teunissen CE, van de Giessen E, Barkhof F, Jonkman LE, van der Lee SJ, de Boer C, Rozemuller AJM, Duits F, Tijms BM, van der Flier WM, Pijnenburg YAL, Coomans EM, Ossenkoppele R. Characterization of individuals fulfilling clinical criteria for limbic-predominant age-related TDP43 encephalopathy (LATE) in a tertiary memory clinic. Alzheimer’s & Dementia. 2025;21(S2):e104809. doi:10.1002/alz70856_104809 | es_ES |
| dc.identifier.uri | https://doi.org/10.1002/alz70856_104809 | |
| dc.identifier.uri | https://repositorio.fleni.org.ar/xmlui/handle/123456789/1567 | |
| dc.description.abstract | Background Limbic-predominant age-related TDP-43 encephalopathy (LATE) clinically mimics and often co-occurs with Alzheimer's disease (AD). Expert consensus criteria have been proposed for the LATE clinical diagnosis, integrating clinical and radiological features, and AD biomarkers. Here, we applied the newly proposed criteria in a tertiary memory clinic population. Method We included participants from the Amsterdam Dementia Cohort aged >50 years who received a diagnosis of MCI or dementia between 1997-2024. Following the LATE consensus criteria scheme (Figure 1), we categorized participants as “Probable LATE”, “Possible LATE” or “Possible LATE-AD” (i.e. LATE clinical and radiological profile with AD biomarker profile). Participants not fulfilling criteria for LATE but fulfilling NIA-AA criteria for AD were categorized as AD. We compared the LATE groups with AD on cognitive decline (N = 1046, N Mean time=2.7[1.8] years) and atrophy (N = 208, Mean time=2.1[1.6]) using linear-mixed effects models, and on mortality rates using Cox proportional hazard models. Result Of the 3367 individuals, 1920 were classified into one of the four groups. Fifty-one (1.5%) were classified as Probable LATE, 102 (3.0%) as Possible LATE, 122 (3.6%) as Possible LATE-AD, and 1645 (48.8%) as AD (Table 1). Compared to AD, Probable LATE showed an attenuated cognitive decline (b[SE] for MMSE=0.12[0.05], p = 0.02) and lower mortality rates (HR[95% CI]=0.75[0.58-0.95], p = 0.02), while individuals with Possible LATE-AD had faster cognitive decline (b for MMSE=-0.12[0.05], p = 0.01) and higher mortality rates (HR=1.55[1.25-1.92], p <0.001, Figure 2). Compared to AD, Probable LATE had, at baseline, lower hippocampal volumes (b=-0.83[0.27], p <0.01), and higher inferior-temporal to hippocampal volume ratios (b=0.81[0.27], p <0.01). Furthermore, in Probable LATE, atrophy in a whole-brain region-of-interest was slower compared to AD (b=0.14[0.08], p = 0.04). Possible LATE-AD had, at baseline, thinner whole-brain cortex (b=-0.69[0.30], p = 0.02), lower hippocampal volumes (b=-1.54[0.31], p <0.01), and higher inferior-temporal to hippocampal volume ratios (b=1.73[0.30], p <0.01) than AD, but there was no difference in atrophy rates between Possible LATE-AD and the other groups (Figure 3). Conclusion In a tertiary memory clinic population, the newly proposed clinical LATE criteria reveal clinical and atrophy trajectories that are distinct from AD, especially for Probable LATE and Possible LATE-AD. Differential clinical and biological disease trajectories highlight the relevance of the LATE classification for diagnostic and prognostic purposes | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Wiley Periodicals LLC on behalf of Alzheimer's Association | es_ES |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Enfermedad de Alzheimer | es_ES |
| dc.subject | Alzheimer Disease | es_ES |
| dc.subject | Proteinopatías TDP-43 | es_ES |
| dc.subject | TDP-43 Proteinopathies | es_ES |
| dc.subject | Pruebas Neuropsicológicas | es_ES |
| dc.subject | Neuropsychological Tests | es_ES |
| dc.title | Characterization of individuals fulfilling clinical criteria for limbic-predominant age-related TDP43 encephalopathy (LATE) in a tertiary memory clinic | es_ES |
| dc.type | Presentation | es_ES |
| dc.type | info:eu-repo/semantics/publishedVersion | |
| dc.description.fil | Fil: Calandri, Ismael Luis. Fleni. Departamento de Neurología. Servicio de Neurología Cognitiva, Neuropsicología y Neuropsiquiatría; Argentina. | |
| dc.relation.ispartofVOLUME | 21 | |
| dc.relation.ispartofNUMBER | S2 | |
| dc.relation.ispartofPAGINATION | e104809 | |
| dc.relation.ispartofCOUNTRY | Estados Unidos | |
| dc.relation.ispartofCITY | Hoboken | |
| dc.relation.ispartofTITLE | Alzheimer's & dementia : the journal of the Alzheimer's Association | |
| dc.relation.ispartofISSN | 1552-5279 | |
| dc.type.snrd | Presentation | es_ES |